{"url_path":"/sec/btcy/10-k/2026/item-9b","section_key":"item-9b","section_title":"Item 9B OTHER INFORMATION**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-14","source_url":"https://www.sec.gov/Archives/edgar/data/1630113/0001493152-26-033207-index.html","accession_number":"0001493152-26-033207","cik":"0001630113","ticker":"BTCY","issuer_name":"BIOTRICITY INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1630113/0001493152-26-033207-index.html","primary_entity_key":"0001630113","primary_entity_name":"BIOTRICITY INC."},"word_count":42,"has_tables":true,"body_markdown":"**ITEM\n9B. OTHER INFORMATION**\n\n \n\nDuring\nthe quarter ended March 31, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement”\nor “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K."}